0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tuberculosis Vaccine Treatment Market Outlook 2022
Published Date: January 2022
|
Report Code: QYRE-Auto-9E9246
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Tuberculosis Vaccine Treatment Market Outlook 2022

Global Tuberculosis Vaccine Treatment Market Outlook 2022

Code: QYRE-Auto-9E9246
Report
January 2022
117 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.
The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.
Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.
Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.

The global Tuberculosis Vaccine Treatment market was valued at US$ 72 million in 2020 and is expected to reach US$ 87 million by the end of 2027, growing at a CAGR of 2.9% during 2021-2027.

This report focuses on Tuberculosis Vaccine Treatment volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Tuberculosis Vaccine Treatment market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Tuberculosis Vaccine Treatment Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

Immune Vaccine
Therapy Vaccine

Segment by Application

Self-Procurement
UNICEF
Other

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

BY COMPANY

Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
1 Tuberculosis Vaccine Treatment Market Overview
1.1 Product Overview and Scope of Tuberculosis Vaccine Treatment
1.2 Tuberculosis Vaccine Treatment Segment by Type
1.2.1 Global Tuberculosis Vaccine Treatment Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 Tuberculosis Vaccine Treatment Segment by Application
1.3.1 Global Tuberculosis Vaccine Treatment Sales Comparison by Application: (2021-2027)
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Global Tuberculosis Vaccine Treatment Market Size Estimates and Forecasts
1.4.1 Global Tuberculosis Vaccine Treatment Revenue 2016-2027
1.4.2 Global Tuberculosis Vaccine Treatment Sales 2016-2027
1.4.3 Tuberculosis Vaccine Treatment Market Size by Region: 2016 Versus 2021 Versus 2027
2 Tuberculosis Vaccine Treatment Market Competition by Manufacturers
2.1 Global Tuberculosis Vaccine Treatment Sales Market Share by Manufacturers (2016-2021)
2.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Tuberculosis Vaccine Treatment Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Tuberculosis Vaccine Treatment Manufacturing Sites, Area Served, Product Type
2.5 Tuberculosis Vaccine Treatment Market Competitive Situation and Trends
2.5.1 Tuberculosis Vaccine Treatment Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Tuberculosis Vaccine Treatment Players Market Share by Revenue
2.5.3 Global Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tuberculosis Vaccine Treatment Retrospective Market Scenario by Region
3.1 Global Tuberculosis Vaccine Treatment Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Tuberculosis Vaccine Treatment Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Tuberculosis Vaccine Treatment Market Facts & Figures by Country
3.3.1 North America Tuberculosis Vaccine Treatment Sales by Country
3.3.2 North America Tuberculosis Vaccine Treatment Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Tuberculosis Vaccine Treatment Market Facts & Figures by Country
3.4.1 Europe Tuberculosis Vaccine Treatment Sales by Country
3.4.2 Europe Tuberculosis Vaccine Treatment Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Tuberculosis Vaccine Treatment Market Facts & Figures by Region
3.5.1 Asia Pacific Tuberculosis Vaccine Treatment Sales by Region
3.5.2 Asia Pacific Tuberculosis Vaccine Treatment Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Tuberculosis Vaccine Treatment Market Facts & Figures by Country
3.6.1 Latin America Tuberculosis Vaccine Treatment Sales by Country
3.6.2 Latin America Tuberculosis Vaccine Treatment Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Tuberculosis Vaccine Treatment Market Facts & Figures by Country
3.7.1 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country
3.7.2 Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Tuberculosis Vaccine Treatment Historic Market Analysis by Type
4.1 Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
4.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2016-2021)
4.3 Global Tuberculosis Vaccine Treatment Price by Type (2016-2021)
5 Global Tuberculosis Vaccine Treatment Historic Market Analysis by Application
5.1 Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
5.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2016-2021)
5.3 Global Tuberculosis Vaccine Treatment Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck Tuberculosis Vaccine Treatment Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Japan BCG Lab
6.2.1 Japan BCG Lab Corporation Information
6.2.2 Japan BCG Lab Description and Business Overview
6.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Japan BCG Lab Tuberculosis Vaccine Treatment Product Portfolio
6.2.5 Japan BCG Lab Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Corporation Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Serum Institute of India Tuberculosis Vaccine Treatment Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
6.4 AJ Vaccines
6.4.1 AJ Vaccines Corporation Information
6.4.2 AJ Vaccines Description and Business Overview
6.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
6.4.4 AJ Vaccines Tuberculosis Vaccine Treatment Product Portfolio
6.4.5 AJ Vaccines Recent Developments/Updates
6.5 BioFarma
6.5.1 BioFarma Corporation Information
6.5.2 BioFarma Description and Business Overview
6.5.3 BioFarma Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
6.5.4 BioFarma Tuberculosis Vaccine Treatment Product Portfolio
6.5.5 BioFarma Recent Developments/Updates
6.6 GreenSignal Bio Pharma
6.6.1 GreenSignal Bio Pharma Corporation Information
6.6.2 GreenSignal Bio Pharma Description and Business Overview
6.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
6.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Portfolio
6.6.5 GreenSignal Bio Pharma Recent Developments/Updates
6.7 China National Biotec
6.6.1 China National Biotec Corporation Information
6.6.2 China National Biotec Description and Business Overview
6.6.3 China National Biotec Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
6.4.4 China National Biotec Tuberculosis Vaccine Treatment Product Portfolio
6.7.5 China National Biotec Recent Developments/Updates
6.8 Biomed Lublin
6.8.1 Biomed Lublin Corporation Information
6.8.2 Biomed Lublin Description and Business Overview
6.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Biomed Lublin Tuberculosis Vaccine Treatment Product Portfolio
6.8.5 Biomed Lublin Recent Developments/Updates
6.9 Taj Pharmaceuticals
6.9.1 Taj Pharmaceuticals Corporation Information
6.9.2 Taj Pharmaceuticals Description and Business Overview
6.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Portfolio
6.9.5 Taj Pharmaceuticals Recent Developments/Updates
6.10 Ataulpho de Paiva
6.10.1 Ataulpho de Paiva Corporation Information
6.10.2 Ataulpho de Paiva Description and Business Overview
6.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Portfolio
6.10.5 Ataulpho de Paiva Recent Developments/Updates
6.11 IVAC
6.11.1 IVAC Corporation Information
6.11.2 IVAC Tuberculosis Vaccine Treatment Description and Business Overview
6.11.3 IVAC Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
6.11.4 IVAC Tuberculosis Vaccine Treatment Product Portfolio
6.11.5 IVAC Recent Developments/Updates
6.12 Queen Saovabha Mem. Inst
6.12.1 Queen Saovabha Mem. Inst Corporation Information
6.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Description and Business Overview
6.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Portfolio
6.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
6.13 Microgen
6.13.1 Microgen Corporation Information
6.13.2 Microgen Tuberculosis Vaccine Treatment Description and Business Overview
6.13.3 Microgen Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Microgen Tuberculosis Vaccine Treatment Product Portfolio
6.13.5 Microgen Recent Developments/Updates
7 Tuberculosis Vaccine Treatment Manufacturing Cost Analysis
7.1 Tuberculosis Vaccine Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Tuberculosis Vaccine Treatment
7.4 Tuberculosis Vaccine Treatment Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Tuberculosis Vaccine Treatment Distributors List
8.3 Tuberculosis Vaccine Treatment Customers
9 Tuberculosis Vaccine Treatment Market Dynamics
9.1 Tuberculosis Vaccine Treatment Industry Trends
9.2 Tuberculosis Vaccine Treatment Growth Drivers
9.3 Tuberculosis Vaccine Treatment Market Challenges
9.4 Tuberculosis Vaccine Treatment Market Restraints
10 Global Market Forecast
10.1 Tuberculosis Vaccine Treatment Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Tuberculosis Vaccine Treatment by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Tuberculosis Vaccine Treatment by Type (2022-2027)
10.2 Tuberculosis Vaccine Treatment Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Tuberculosis Vaccine Treatment by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Tuberculosis Vaccine Treatment by Application (2022-2027)
10.3 Tuberculosis Vaccine Treatment Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Tuberculosis Vaccine Treatment by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Tuberculosis Vaccine Treatment by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
    Table 1. Global Tuberculosis Vaccine Treatment Sales (K Dose) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Tuberculosis Vaccine Treatment Sales (K Dose) Comparison by Application (2021-2027)
    Table 3. Global Tuberculosis Vaccine Treatment Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Tuberculosis Vaccine Treatment Covered in This Study
    Table 5. Global Tuberculosis Vaccine Treatment Sales (K Dose) of Key Manufacturers (2016-2021)
    Table 6. Global Tuberculosis Vaccine Treatment Sales Market Share by Manufacturers (2016-2021)
    Table 7. Global Tuberculosis Vaccine Treatment Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Tuberculosis Vaccine Treatment Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Tuberculosis Vaccine Treatment Average Price (USD/K Dose) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Tuberculosis Vaccine Treatment Manufacturing Sites and Area Served
    Table 11. Manufacturers Tuberculosis Vaccine Treatment Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Tuberculosis Vaccine Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Vaccine Treatment as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Tuberculosis Vaccine Treatment Sales by Region (2016-2021) & (K Dose)
    Table 16. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2016-2021)
    Table 17. Global Tuberculosis Vaccine Treatment Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose)
    Table 19. North America Tuberculosis Vaccine Treatment Sales Market Share by Country (2016-2021)
    Table 20. North America Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Tuberculosis Vaccine Treatment Revenue Market Share by Country (2016-2021)
    Table 22. Europe Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose)
    Table 23. Europe Tuberculosis Vaccine Treatment Sales Market Share by Country (2016-2021)
    Table 24. Europe Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Tuberculosis Vaccine Treatment Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Tuberculosis Vaccine Treatment Sales by Region (2016-2021) & (K Dose)
    Table 27. Asia Pacific Tuberculosis Vaccine Treatment Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Tuberculosis Vaccine Treatment Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Tuberculosis Vaccine Treatment Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose)
    Table 31. Latin America Tuberculosis Vaccine Treatment Sales Market Share by Country (2016-2021)
    Table 32. Latin America Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Tuberculosis Vaccine Treatment Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose)
    Table 35. Middle East and Africa Tuberculosis Vaccine Treatment Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Tuberculosis Vaccine Treatment Revenue Market Share by Country (2016-2021)
    Table 38. Global Tuberculosis Vaccine Treatment Sales (K Dose) by Type (2016-2021)
    Table 39. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
    Table 40. Global Tuberculosis Vaccine Treatment Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Tuberculosis Vaccine Treatment Revenue Share by Type (2016-2021)
    Table 42. Global Tuberculosis Vaccine Treatment Price (USD/K Dose) by Type (2016-2021)
    Table 43. Global Tuberculosis Vaccine Treatment Sales (K Dose) by Application (2016-2021)
    Table 44. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
    Table 45. Global Tuberculosis Vaccine Treatment Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Tuberculosis Vaccine Treatment Revenue Share by Application (2016-2021)
    Table 47. Global Tuberculosis Vaccine Treatment Price (USD/K Dose) by Application (2016-2021)
    Table 48. Merck Corporation Information
    Table 49. Merck Description and Business Overview
    Table 50. Merck Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 51. Merck Tuberculosis Vaccine Treatment Product
    Table 52. Merck Recent Developments/Updates
    Table 53. Japan BCG Lab Corporation Information
    Table 54. Japan BCG Lab Description and Business Overview
    Table 55. Japan BCG Lab Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 56. Japan BCG Lab Tuberculosis Vaccine Treatment Product
    Table 57. Japan BCG Lab Recent Developments/Updates
    Table 58. Serum Institute of India Corporation Information
    Table 59. Serum Institute of India Description and Business Overview
    Table 60. Serum Institute of India Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 61. Serum Institute of India Tuberculosis Vaccine Treatment Product
    Table 62. Serum Institute of India Recent Developments/Updates
    Table 63. AJ Vaccines Corporation Information
    Table 64. AJ Vaccines Description and Business Overview
    Table 65. AJ Vaccines Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 66. AJ Vaccines Tuberculosis Vaccine Treatment Product
    Table 67. AJ Vaccines Recent Developments/Updates
    Table 68. BioFarma Corporation Information
    Table 69. BioFarma Description and Business Overview
    Table 70. BioFarma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 71. BioFarma Tuberculosis Vaccine Treatment Product
    Table 72. BioFarma Recent Developments/Updates
    Table 73. GreenSignal Bio Pharma Corporation Information
    Table 74. GreenSignal Bio Pharma Description and Business Overview
    Table 75. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 76. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product
    Table 77. GreenSignal Bio Pharma Recent Developments/Updates
    Table 78. China National Biotec Corporation Information
    Table 79. China National Biotec Description and Business Overview
    Table 80. China National Biotec Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 81. China National Biotec Tuberculosis Vaccine Treatment Product
    Table 82. China National Biotec Recent Developments/Updates
    Table 83. Biomed Lublin Corporation Information
    Table 84. Biomed Lublin Description and Business Overview
    Table 85. Biomed Lublin Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 86. Biomed Lublin Tuberculosis Vaccine Treatment Product
    Table 87. Biomed Lublin Recent Developments/Updates
    Table 88. Taj Pharmaceuticals Corporation Information
    Table 89. Taj Pharmaceuticals Description and Business Overview
    Table 90. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 91. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product
    Table 92. Taj Pharmaceuticals Recent Developments/Updates
    Table 93. Ataulpho de Paiva Corporation Information
    Table 94. Ataulpho de Paiva Description and Business Overview
    Table 95. Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 96. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product
    Table 97. Ataulpho de Paiva Recent Developments/Updates
    Table 98. IVAC Corporation Information
    Table 99. IVAC Description and Business Overview
    Table 100. IVAC Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 101. IVAC Tuberculosis Vaccine Treatment Product
    Table 102. IVAC Recent Developments/Updates
    Table 103. Queen Saovabha Mem. Inst Corporation Information
    Table 104. Queen Saovabha Mem. Inst Description and Business Overview
    Table 105. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 106. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product
    Table 107. Queen Saovabha Mem. Inst Recent Developments/Updates
    Table 108. Microgen Corporation Information
    Table 109. Microgen Description and Business Overview
    Table 110. Microgen Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (Million US$), Price (USD/K Dose) and Gross Margin (2016-2021)
    Table 111. Microgen Tuberculosis Vaccine Treatment Product
    Table 112. Microgen Recent Developments/Updates
    Table 113. Production Base and Market Concentration Rate of Raw Material
    Table 114. Key Suppliers of Raw Materials
    Table 115. Tuberculosis Vaccine Treatment Distributors List
    Table 116. Tuberculosis Vaccine Treatment Customers List
    Table 117. Tuberculosis Vaccine Treatment Market Trends
    Table 118. Tuberculosis Vaccine Treatment Growth Drivers
    Table 119. Tuberculosis Vaccine Treatment Market Challenges
    Table 120. Tuberculosis Vaccine Treatment Market Restraints
    Table 121. Global Tuberculosis Vaccine Treatment Sales Forecast by Type (2022-2027) & (K Dose)
    Table 122. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Type (2022-2027)
    Table 123. Global Tuberculosis Vaccine Treatment Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 124. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Type (2022-2027)
    Table 125. Global Tuberculosis Vaccine Treatment Sales Forecast by Application (2022-2027) & (K Dose)
    Table 126. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Application (2022-2027)
    Table 127. Global Tuberculosis Vaccine Treatment Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 128. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Application (2022-2027)
    Table 129. Global Tuberculosis Vaccine Treatment Sales Forecast by Region (2022-2027) & (K Dose)
    Table 130. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Region (2022-2027)
    Table 131. Global Tuberculosis Vaccine Treatment Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 132. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Region (2022-2027)
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Tuberculosis Vaccine Treatment
    Figure 2. Global Tuberculosis Vaccine Treatment Market Share by Type in 2020 & 2027
    Figure 3. Immune Vaccine Product Picture
    Figure 4. Therapy Vaccine Product Picture
    Figure 5. Global Tuberculosis Vaccine Treatment Market Share by Application in 2020 & 2027
    Figure 6. Self-Procurement
    Figure 7. UNICEF
    Figure 8. Other
    Figure 9. Global Tuberculosis Vaccine Treatment Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Tuberculosis Vaccine Treatment Market Size 2016-2027 (US$ Million)
    Figure 11. Global Tuberculosis Vaccine Treatment Sales 2016-2027 (K Dose)
    Figure 12. Global Tuberculosis Vaccine Treatment Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 13. Tuberculosis Vaccine Treatment Sales Share by Manufacturers in 2020
    Figure 14. Global Tuberculosis Vaccine Treatment Revenue Share by Manufacturers in 2020
    Figure 15. The Global 5 and 10 Largest Tuberculosis Vaccine Treatment Players: Market Share by Revenue in 2020
    Figure 16. Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 17. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2016-2021)
    Figure 18. Global Tuberculosis Vaccine Treatment Sales Market Share by Region in 2020
    Figure 19. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2016-2021)
    Figure 20. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region in 2020
    Figure 21. U.S. Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 22. Canada Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 23. Germany Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. France Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. U.K. Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. Italy Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. Russia Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. China Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. Japan Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. South Korea Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. India Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. Australia Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. Taiwan Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. Indonesia Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Thailand Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Malaysia Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Philippines Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Vietnam Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Mexico Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Brazil Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Argentina Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Turkey Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Saudi Arabia Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. UAE Tuberculosis Vaccine Treatment Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Sales Market Share of Tuberculosis Vaccine Treatment by Type (2016-2021)
    Figure 46. Sales Market Share of Tuberculosis Vaccine Treatment by Application (2016-2021)
    Figure 47. Sales Market Share of Tuberculosis Vaccine Treatment by Application in 2020
    Figure 48. Revenue Share of Tuberculosis Vaccine Treatment by Application (2016-2021)
    Figure 49. Revenue Share of Tuberculosis Vaccine Treatment by Application in 2020
    Figure 50. Manufacturing Cost Structure of Tuberculosis Vaccine Treatment
    Figure 51. Manufacturing Process Analysis of Tuberculosis Vaccine Treatment
    Figure 52. Tuberculosis Vaccine Treatment Industrial Chain Analysis
    Figure 53. Channels of Distribution
    Figure 54. Distributors Profiles
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$2900
This license allows only one user to access the PDF.

Electronic (PDF)
$4350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$5800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Leap India

RELATED REPORTS

Global Vaccine Temperature Monitoring System Market Insights Forecast to 2028
Global Vaccine Temperature Monitoring System Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-10F7540
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Nelfinavir Market Insights Forecast to 2028
Global Nelfinavir Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-25I7469
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Vancomycin Market Insights and Forecast to 2028
Global Vancomycin Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-20N7760
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Hepatitis B Human Immunoglobulin Market Insights and Forecast to 2028
Global Hepatitis B Human Immunoglobulin Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-22V7718
Tue May 03 00:00:00 UTC 2022

Add to Cart